Lifecome Biochemistry Co (SZSE:002868) LT-Debt-to-Total-Asset : 0.28 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Lifecome Biochemistry Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lifecome Biochemistry Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.28.

Lifecome Biochemistry Co's long-term debt to total assets ratio increased from Mar. 2023 (0.08) to Mar. 2024 (0.28). It may suggest that Lifecome Biochemistry Co is progressively becoming more dependent on debt to grow their business.

Lifecome Biochemistry Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lifecome Biochemistry Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecome Biochemistry Co LT-Debt-to-Total-Asset Chart

Lifecome Biochemistry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.06

0.08

0.09

0.27

Lifecome Biochemistry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.08	0.11	0.28	0.27	0.28

Lifecome Biochemistry Co LT-Debt-to-Total-Asset Calculation

Lifecome Biochemistry Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	527.004	/	1965.009
	=	0.27

Lifecome Biochemistry Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	540.438	/	1953.475
	=	0.28

Lifecome Biochemistry Co (SZSE:002868) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lifecome Biochemistry Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lifecome Biochemistry Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecome Biochemistry Co (SZSE:002868) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lifecome Biochemistry Co Ltd (SZSE:002868) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.19, Nanpu Ecological Industrial Park, Pucheng, Fujian, CHN, 353400

Website

http://www.pclifecome.com

Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.

Executives

Lou Li Jun	Supervisors
Huang Hui	Executives
Bao Zhong Shou	Executives
Feng Zhen Wu	Supervisors
Li Jun Hui	Executives
Lai Tan Ping	Directors, executives
Xu Chun Lin	Director
Lai Jian Ping	Directors, executives

Lifecome Biochemistry Co (SZSE:002868) Headlines

No Headlines